Ticker > Company >

Aakaar Medical Tech. share price

Aakaar Medical Technologies Ltd.

NSE: AAKAAR SECTOR: Trading  5.62 K   2   1

71.70
-2.40 (-3.24%)
NSE: 30 Jun 4:00 PM

Price Summary

Today's High

₹ 72.05

Today's Low

₹ 71.1

52 Week High

₹ 105

52 Week Low

₹ 46

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

101.62 Cr.

Enterprise Value

103.91 Cr.

No. of Shares

1.42 Cr.

P/E

15.31

P/B

1.86

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  38.49

CASH

16.24 Cr.

DEBT

18.53 Cr.

Promoter Holding

67.05 %

EPS (TTM)

₹  4.68

Sales Growth

8.74%

ROE

17.06 %

ROCE

18.45%

Profit Growth

10.03 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.74%
3 Year26.88%
5 YearNA

Profit Growth

1 Year10.03%
3 Year45.54%
5 YearNA

ROE%

1 Year17.06%
3 Year25.55%
5 Year24.24%

ROCE %

1 Year18.45%
3 Year22.81%
5 Year22.93%

Debt/Equity

0.3398

Price to Cash Flow

-12.15

Interest Cover Ratio

6.1176

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 67.05 0.00
Sep 2025 67.01 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 26.878980915756% for the Past 3 years.
  • Company has been maintaining healthy ROE of 25.5528666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 22.8131666666667% over the past 3 years.
  • Company has a healthy liquidity position with current ratio of 3.2059.
  • The company has a high promoter holding of 67.05%.
  • Promoter stake has increased from 0% to 67.01% in the last 1 quarter.

 Limitations

  • Company has negative cash flow from operations of -8.3613.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 19.47 32.78 46.11 61.58 66.96
Total Expenditure 17.07 29.26 41.11 51.81 56.65
Operating Profit 2.4 3.53 5 9.77 10.31
Other Income 0.04 0.09 0.16 0.18 0.8
Interest 0.21 0.43 1.14 1.71 1.8
Depreciation 0.02 0.09 0.14 0.12 0.13
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.2 3.1 3.89 8.11 9.19
Tax 0.59 0.95 1.02 2.08 2.55
Net Profit 1.62 2.15 2.87 6.03 6.64
Adjusted EPS (Rs.) 1.69 2.25 3 5.79 4.68

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 0.7 0.7 0.7 10.42 14.17
Total Reserves 7.33 8.96 11.84 12.84 40.38
Borrowings 0 0 0 0 0
Other N/C liabilities 0.32 0.4 1.59 2.48 0.51
Current liabilities 9.45 12.91 20.64 30.04 23.9
Total Liabilities 17.8 22.97 34.77 55.77 78.97
Assets
Net Block 0.2 0.36 0.28 0.24 0.29
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0.4
Investments 0 0 0 0 0
Loans & Advances 0.11 0.16 1.45 3.01 1.09
Other N/C Assets 0.16 0.22 0.23 0.61 0.56
Current Assets 17.33 22.22 32.81 51.91 76.63
Total Assets 17.8 22.97 34.77 55.77 78.97
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 2.2 3.1 3.89 8.11 9.19
Adjustment 0.17 0.83 1.06 1.58 1.29
Changes in Assets & Liabilities -1.25 -5.82 -11.73 -13.12 -16.6
Tax Paid -0.64 -1.04 -1.26 -1.99 -2.25
Operating Cash Flow 0.48 -2.93 -8.04 -5.41 -8.36
Investing Cash Flow -0.23 -0.32 -0.04 -0.05 0.05
Financing Cash Flow -0.81 1.17 8.19 10.71 18.8
Net Cash Flow -0.55 -2.08 0.11 5.25 10.48

Corporate Actions

Investors Details

PARTICULARS Sep 2025% Mar 2026%
promoters 67.01 67.05
abhash meswani 2.50 2.50
bindi dilip meswani 12.84 12.84
dilip ramesh meswani 48.16 48.20
milouni dilip meswani 1.49 1.49
sharda rameshchandra mesw... 2.02 2.02
PARTICULARS Sep 2025% Mar 2026%
investors 32.99 32.95
aarth aif growth fund 3.29 3.61
chaitanya gadia - 1.20
grobiz sme opportunity fu... 1.10 1.10
india equity fund 1 4.96 4.97
rahul b sawakhande 4.10 4.10

Annual Reports

Title Link
Title Link
Annual Report 2025

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY26

Aakaar Medical Tech. Stock Price Analysis and Quick Research Report. Is Aakaar Medical Tech. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Aakaar Medical Tech.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Aakaar Medical Tech. has a PE ratio of 15.3087368690751 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Aakaar Medical Tech. has ROA of 9.8527% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Aakaar Medical Tech. has a Current ratio of 3.2059.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Aakaar Medical Tech. has a ROE of 17.0613%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Aakaar Medical Tech. has a Debt to Equity ratio of 0.3398 which means that the company has low proportion of debt in its capital.

  • Sales growth: Aakaar Medical Tech. has reported revenue growth of 8.7383% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Aakaar Medical Tech. for the current financial year is 15.3989973732194%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Aakaar Medical Tech. is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Aakaar Medical Tech. is Rs 4.6836. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Aakaar Medical Tech. in Ticker for free. Also, one can get the intrinsic value of Aakaar Medical Tech. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Aakaar Medical Tech. FAQs

Q1. What is Aakaar Medical Tech. share price today?
Ans: The current share price of Aakaar Medical Tech. is Rs 71.7.

Q2. What is the market capitalisation of Aakaar Medical Tech.?
Ans: Aakaar Medical Tech. has a market capitalisation of Rs 101.61909072 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Aakaar Medical Tech.?
Ans: The PE ratio of Aakaar Medical Tech. is 15.3087368690751 and the P/B ratio of Aakaar Medical Tech. is 1.8628408713003, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Aakaar Medical Tech. share?
Ans: The 52-week high share price of Aakaar Medical Tech. is Rs 105, and the 52-week low share price of Aakaar Medical Tech. is Rs 46.

Q5. Does Aakaar Medical Tech. pay dividends?
Ans: Currently, Aakaar Medical Tech. does not pay dividends. Dividend yield of Aakaar Medical Tech. is around 0%.

Q6. What are the face value and book value of Aakaar Medical Tech. shares?
Ans: The face value of Aakaar Medical Tech. shares is Rs 10, while the book value per share of Aakaar Medical Tech. is around Rs 38.4896. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Aakaar Medical Tech.?
Ans: Aakaar Medical Tech. has a total debt of Rs 18.5343 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Aakaar Medical Tech.?
Ans: The ROE of Aakaar Medical Tech. is 17.0613% and ROCE of Aakaar Medical Tech. is 18.4544%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Aakaar Medical Tech. a good buy for the long term?
Ans: The Aakaar Medical Tech. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Aakaar Medical Tech. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Aakaar Medical Tech. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Aakaar Medical Tech.’s financials?
Ans: You can review Aakaar Medical Tech.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Aakaar Medical Tech.
X